CAR T cells for treating autoimmune diseases Ulrich Blache, Sandy Tretbar, Ulrike Koehl, Dimitrios Mougiakakos, Stephan Fricke
23 November 2023
Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants Ling-Qiong Jiang, Ruo-Di Zhang, Harry Asena Musonye, Hao-Yun Zhao, Yi-Sheng He, Chan-Na Zhao, Tian He, Tian Tian, Zhao-Xing Gao, Yang Fang, Peng Wang, Jing Ni, Hai-Feng Pan
9 January 2024
Association between sinusitis and incident rheumatic diseases: a population-based study Vanessa L Kronzer, John M Davis, Andrew C Hanson, Jeffrey A Sparks, Elena Myasoedova, Ali Duarte-Garcia, Alicia M Hinze, Ashima Makol, Mattew J Koster, Robert Vassallo, Kenneth J Warrington, Kerry Wright, Cynthia S Crowson
22 February 2024
Re-evaluating the mythical divide between traditional and novel cardiovascular risk factors in rheumatoid arthritis Eirik Ikdahl, Mats Julius Stensrud
1 March 2024
Characterisation of airway disease associated with Sjögren disease Loïc Meudec, Marie-Pierre Debray, Antoine Beurnier, Cindy Marques, Pierre-Antoine Juge, Robin Dhote, Claire Larroche, Anne Laure Fauchais, Emanuelle Dernis, Olivier Vittecoq, Alain Saraux, Jacques-Eric Gottenberg, Eric Hachulla, Véronique Le Guern, Philippe DieudéSee the full list of authors
29 February 2024
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study Maxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ryussen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
29 February 2024
Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis Paul J Scherbacher, Bernhard Hellmich, You-Shan Feng, Christian Löffler
29 February 2024
Validity of an ultrasonographic joint-specific scoring system in juvenile idiopathic arthritis: a cross-sectional study comparing ultrasound findings of synovitis with whole-body magnetic resonance imaging and clinical assessment Nina Krafft Sande, Eva Kirkhus, Vibke Lilleby, Anders Høye Tomterstad, Anna-Birgitte Aga, Berit Flatø, Pernille Bøyesen
1 March 2024
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis Philip J Mease, Soumya Reddy, Sarah Ross, Jeffrey R Lisse, Paulo Reis, Kirstin Griffing, Christophe Sapin, Aisha Vadhariya, Daniel E Furst
31 January 2024
Global, regional and national burdens of gout in the young population from 1990 to 2019: a population-based study Jing Zhang, Chenye Jin, Bing Ma, Hao Sun, Yanmei Chen, Ying Zhong, Cheng Han, Tingting Liu, Yongze Li
24 April 2023
VEXAS syndrome: a diagnostic puzzle Nikolas Ruffer, Martin Krusche
2 August 2023
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the ‘Plants for Joints’ randomised clinical trial Carlijn A Wagenaar, Wendy Walrabenstein, Marike van der Leeden, Franktien Turkstra, Martijn Gerritsen, Jos W R Twisk, Maarten Boers, Martin van der Esch, Henriët van Middendorp, Peter J M Weijs, Dirkjan van Schaardenburg
27 February 2024
Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease Johanna Bausson, Nicolas Keller, Jean-Jacques Von Hunolstein, Matthieu Sacrez, Bruno Michel, Bénédicte Gourieux, Marion Fourtage, Renaud Felten
31 January 2024
Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study Charlotte Laurent, Laure Ricard, Yann Nguyen, Jean Jacques Boffa, Eric Rondeau, Grigorios Gerotziafas, Ismail Elalamy, Sophie Deriaz, Claire De Moreuil, Virginie Planche, Cathererine Johanet, Francois Millot, Olivier Fain, Arsène Mekinian
31 March 2023
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL Laura C Coates, Robert Landewé, Iain B McInnes, Philip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana-Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan BajracharyaSee the full list of authors
22 February 2024
Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose? Catia Duarte, Ricardo J O Ferreira, Paco M J Welsing, Johannes W G Jacobs, Laure Gossec, Pedro M Machado, Désirée van der Heijde, Jose Antonio Pereira da Silva
4 March 2024
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease Claire Rempenault, Cédric Lukas, Léa Tardivon, Claire Immediato Daien, Bernard Combe, Philippe Guilpain, Jacques Morel
30 January 2024
Effect of high-intensity interval training in physiotherapy primary care for patients with inflammatory arthritis: the ExeHeart randomised controlled trial Kristine Røren Nordén, Anne Grete Semb, Hanne Dagfinrud, Jonny Hisdal, Joseph Sexton, Camilla Fongen, Emilie Bakke, Sigrid Ødegård, Jon Skandsen, Thalita Blanck, George S Metsios, Anne Therese Tveter
18 January 2024
Methotrexate in pregnancy: still many unanswered questions Corinna Weber-Schoendorfer, Orna Diav-Citrin
15 March 2023
Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study Faustino Peron Filho, Andressa de Souza Moreira, Anna Larissa Faria Janes, Alexandre W S de Souza
4 March 2024